Common Questions About the Management of Gastroesophageal Reflux Disease

Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. 25.

The reflux gets there in liquid form and damages the mucous membrane. The results are pain (heartburn) in the short term and more serious risks – like cancer – in the long term. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Surgery should be reserved for patients with contraindications to PPI therapy or when symptoms remain poorly controlled despite lifestyle changes and maximal PPI doses. Medical treatment should be optimized, medication adherence should be addressed, and risks associated with surgery should be carefully considered when weighing treatment options .

The authors performed a 10-year, open label, prospective follow-up of patients with refractory GERD who were treated with the Stretta procedure. Out of 217 that reached the 10-year follow-up, 72% had normalization of health-related quality of life and 64% had greater than 50% reduction in baseline PPI use with discontinuation in 41% at the 10-year mark. Despite the conflicting results current evidence suggests that the Stretta procedure is an effective therapeutic modality for patients with GERD.

Some studies have warned of doctors being too quick to prescribe PPIs and patients staying on them for too long. Others have found little reason for concern.

Nevertheless, gastroscopy remains an important screening tool to exclude an underlying organic lesion of the upper gastrointestinal tract and allow for oesophageal biopsies in conditions such as pill-induced oesophagitis, skin diseases with oesophageal involvement, peptic ulceration of the oesophagus and eosinophilic oesophagitis. Ms Olivia has been troubled by symptoms that resemble gastro-oesophageal reflux disease since her 40th birthday several years ago. She was prescribed proton pump inhibitors by several different doctors and has been taking them regularly with no improvement. She underwent gastroscopy about five years ago that reported normal results. In recent months, she underwent a cardiac evaluation that was also normal.

If a patient’s symptoms responded to PPIs, they had GERD and conversely, if they did not respond to PPIs, they did not have GERD. Or so the thinking went. This was, of course, flawed thinking, as it would equate to diagnosing rheumatoid arthritis based on improvement with aspirin therapy [3]. While it is true that many cases of rheumatoid arthritis do respond to aspirin, it is also true that many do not and, for that matter, that many other conditions may exhibit a therapeutic response to aspirin. And then there is the placebo response.

Their findings build on several other recent studies that found previously unknown correlations of PPIs and chronic and acute conditions. Together, the studies associated PPI use with a 44 percent heightened risk of developing dementia, 44 percent heightened risk for osteoporotic bone fractures, 20 percent heightened risk for heart attack, 70 percent heightened risk for clostridium difficile infections (which can be life-threatening), 30 to 50 percent heightened risk for chronic kidney disease, and an increased risk of stomach cancer. We tend to call it heartburn or acid reflux, but what we most often mean is Gastroesophaegeal Reflux Disease (GERD), in which the contents of the stomach escape up into the esophagus. GERD is one of the most common chronic ailments in the US; an estimated 20 to 60 percent of Americans have it at some point in any given year, and many don’t even know it.

What Drugs Interact with Proton Pump Inhibitors vs. Zantac?

Most people only reflux much smaller amounts of acid in their throat than they drink or eat. For GERD, they work really well. Most patients recover from their symptoms in a few weeks.

Stomach acid is needed to break down food and absorb nutrients, he said, as well as for proper functioning of the gallbladder and pancreas. Long-term of use of P.P.I.’s may interfere with these processes, he noted. And suppression of stomach acid, which kills bacteria and other microbes, may make people more susceptible to infections, like C.

Licorice and chamomile are sometimes used to ease GERD. Herbal remedies can have serious side effects and might interfere with medications. Ask your doctor about a safe dosage before beginning any herbal remedy.

User Reviews for Dexilant to treat GERD

Medicine names that end in “prazole” are PPIs. Maintain a healthy weight. Excess pounds put pressure on your abdomen, pushing up your stomach and causing acid to reflux into your esophagus. Prescription-strength proton pump inhibitors.

However, nearly all physicians have had the experience of switching from one PPI to another successfully. While the newer medications, rabeprazole (Aciphex) and pantoprazole (Protonix) have data to suggest better suppression of stomach acid compared to omeprazole, there is no proof that the differences are clinically important. Rabeprazole and pantoprazole are smaller and may be better for patients who have problems swallowing capsules. Pantoprazole is marketed as being cheaper, and may be better for patients paying for their own medications. However, side effects can occur, and some people are at increased risk for adverse events (see below).

However, research now suggests that certain risks may be involved with long-term use of these drugs. Most people will benefit from first-stage treatments by adjusting how, when, and what they eat. However, diet and lifestyle adjustments alone may not be effective for some. In theses cases, doctors may recommend using medications that slow or stop acid production in the stomach.

And, the drugs can also halt the production of stomach acid that causes ulcers with long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), like aspirin and ibuprofen (Advil or Motrin). Nearly all adverse effects associated with PPIs occur among patients who receive long-term therapy. It is important to note, however, that most studies published have been observational in nature and do not necessarily suggest a causal relationship. Pharmacists are in an ideal position to ensure appropriate and effective use and reduce PPI overuse.

The research is published online July 3 in the journal BMJ Open. Patients may be under the impression that pharmacologic treatment is the only option for GERD, or some patients may be more interested in nonmedication options to help control symptoms. In any case, lifestyle modifications can improve symptoms considerably when combined with other options.

Leave a Reply

November 4, 2014

Posted In:

Tags: , , , , , ,

Leave a Comment